hotspot -WSS

hotspot

author：Wikipedia 2025-09-28 19:19:15 - browse：7683

Biotech startup Generate Biomedicines, which uses artificial intelligence to find new drugs, raised $273 million in a Series C funding round from investors including pharma company Amgen and the VC arm of AI giant NVIDIA.

Generate was founded in 2018 by venture-creation firm Flagship Pioneering to use machine learning algorithms to identify antibodies, peptides, cell therapies, and other medicines. It launched its first clinical trial in July for a Covid monoclonal antibody, and is working on starting another clinical trial for an asthma treatment.

The biotech, which is based in Somerville, Mass., has big plans for the next couple of years: It has another 15 drug candidates in the works and plans to introduce 10 more annually, CEO Mike Nally told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： NIH director takes cautious approach to Biden drug pricing priority

WSS

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Woman gored by Bison at Yellowstone

Francis Collins on trust in science and how Covid communications failed

Celiac disease study examines precisely how gluten triggers injury

Eli Lilly, Pfizer, and others want in on the online prescription market

Independent physicians launch a new lobbying group

hotspot

hotspot

focus

Hollywood unions extend contract negotiations for actors

Congress likely to miss an opportunity to fix drug shortages issue

What does generative AI mean for health care? We asked experts

Biotech venture capitalists face new demands from investors

Heart attack and stroke risk calculators need revising

The new HIV moral panic

The high cost of giving birth even with insurance

Can CDC director Mandy Cohen drive consensus in Washington?

Moonlake's readout produced a cash windfall. Risks remain

Mike Pence clashes with Tucker Carlson in Iowa

leisure time

Research misconduct: Proposed new rules face resistance

Dewpoint Therapeutics lays off staff after losing partnerships

Congress likely to miss an opportunity to fix drug shortages issue

Congress likely to miss an opportunity to fix drug shortages issue

How digital therapeutics firms are pivoting after Pear's bankruptcy

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

explore

Wikipedia

leisure time

hotspot